Gentamicin

Generic Name
Gentamicin
Brand Names
Gentak, Pred-G, Valisone-G
Drug Type
Small Molecule
Chemical Formula
C60H123N15O21
CAS Number
1403-66-3
Unique Ingredient Identifier
T6Z9V48IKG
Background

Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from Micromonospora purpurea in 1963. It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability. Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment ...

Indication

1.本品适用于敏感铜绿假单胞菌、变形杆菌(吲哚阳性和阴性)属、大肠埃希菌、克雷伯菌属、肠杆菌属、沙雷菌属、柠檬酸杆菌属以及葡萄球菌属(不包括耐甲氧西林菌株)所致的严重感染;临床上本品常与β内酰胺类或其他抗菌药物联合应用。本品与青霉素G(或氨苄西林)联合应用治疗肠球菌感染;

2.本品用于铜绿假单胞菌或葡萄球菌属所致的严重中枢神经系统感染(如脑膜炎、脑室炎)时,可同时用本品鞘内注射作为辅助治疗;

3.本品不适用于单纯性尿路感染初治,除非病原菌对其他毒性较低的抗菌药物不敏感,本品对链球菌属中多数菌种(尤其D组)、肺炎链球菌和厌氧菌(如拟杆菌属或梭状芽孢杆菌属)无效;

4.本品口服可用于肠道感染或结肠手术前准备,也可用本品肌注合并克林霉素或甲硝唑以减少结肠手术后感染率。
...

Associated Conditions
Allergic Conjunctivitis (AC), Bacterial Conjunctivitis, Bacterial Infections, Bacterial Keratitis, Bacterial Peritonitis, Bacterial dacryocystitis, Blepharoconjunctivitis, Central Nervous System Infections, Corneal infection, Dermatitis infected, Ecthyma, Eczematous dermatitis infected, Folliculitis, Furunculosis, Gram-negative enteric bacilli neonatal sepsis, Impetigo contagious, Inflammation, Keratoconjunctivitis, Meibomianitis, Meningitis, Bacterial, Ocular Inflammation, Pustular Psoriasis (PP), Pustular acne, Pyoderma Gangrenosum, Seborrheic Dermatitis, Septicemia gram-negative, Skin Infections, Skin and Subcutaneous Tissue Bacterial Infections, Sycosis barbae, Bacterial blepharitis, Bacterial corneal ulcers, Bacterial skin infections, Complicated Respiratory tract infection bacterial, Complicated Urinary Tract Infection caused by susceptible bacteria, Corticosteroid-responsive dermatoses, Ocular bacterial infections, Severe Endocarditis enterococcal, Severe Infection Pseudomonas aeruginosa, Severe Staphylococcal infection
Associated Therapies
-

Long Term Nebulised Gentamicin in Patients With Bronchiectasis

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-09-09
Last Posted Date
2010-08-10
Lead Sponsor
University of Edinburgh
Target Recruit Count
60
Registration Number
NCT00749866
Locations
🇬🇧

Royal Infirmary of Edinburgh, Edinburgh, Lothian, United Kingdom

Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate

Phase 4
Conditions
First Posted Date
2007-05-30
Last Posted Date
2007-05-30
Lead Sponsor
HaEmek Medical Center, Israel
Target Recruit Count
160
Registration Number
NCT00480376
Locations
🇮🇱

Urology outpatient clinic, HaEmek MC, Afula, Israel

Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2007-04-25
Last Posted Date
2013-05-29
Lead Sponsor
Julie Wei, MD
Target Recruit Count
40
Registration Number
NCT00465530
Locations
🇺🇸

University of Kansas MedWest, Shawnee, Kansas, United States

🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients

Phase 2
Terminated
Conditions
First Posted Date
2006-09-14
Last Posted Date
2015-02-25
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
20
Registration Number
NCT00376428
Locations
🇫🇷

Necker-Enfants malades, Paris, France

Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy

First Posted Date
2005-09-21
Last Posted Date
2016-10-27
Lead Sponsor
University of Wisconsin, Madison
Target Recruit Count
150
Registration Number
NCT00214331
Locations
🇺🇸

University of Wisconsin, Madison, Wisconsin, United States

Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2005-09-16
Last Posted Date
2011-06-15
Lead Sponsor
Stanford University
Target Recruit Count
126
Registration Number
NCT00185991
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

Treatment and Diagnosis of Plague

Phase 2
Completed
Conditions
First Posted Date
2005-08-10
Last Posted Date
2009-02-26
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
114
Registration Number
NCT00128466
Locations
🇲🇬

Ministry of Health, Antananarivo, Madagascar

Gentamicin Treatment of Muscular Dystrophy

First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
4
Registration Number
NCT00005574
Locations
🇺🇸

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath